Correlation Between Tekla Life and Flaherty

Can any of the company-specific risk be diversified away by investing in both Tekla Life and Flaherty at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Life and Flaherty into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tekla Life Sciences and Flaherty and Crumrine, you can compare the effects of market volatilities on Tekla Life and Flaherty and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Life with a short position of Flaherty. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Life and Flaherty.

Diversification Opportunities for Tekla Life and Flaherty

0.75

Correlation Coefficient

Tekla Life  Flaherty

Poor diversification

The 3 months correlation between Tekla and Flaherty is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Life Sciences and Flaherty and Crumrine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Flaherty and Crumrine and Tekla Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Life Sciences are associated (or correlated) with Flaherty. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Flaherty and Crumrine has no effect on the direction of Tekla Life i.e., Tekla Life and Flaherty go up and down completely randomly.

Pair Corralation between Tekla Life and Flaherty

Considering the 90-day investment horizon Tekla Life is expected to generate 1.19 times less return on investment than Flaherty. In addition to that, Tekla Life is 1.28 times more volatile than Flaherty and Crumrine. It trades about 0.05 of its total potential returns per unit of risk. Flaherty and Crumrine is currently generating about 0.07 per unit of volatility. If you would invest  1,595  in Flaherty and Crumrine on November 28, 2024 and sell it today you would earn a total of  449.21  from holding Flaherty and Crumrine or generate 28.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Tekla Life Sciences  vs.  Flaherty and Crumrine

Tekla Life Sciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tekla Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Tekla Life is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Flaherty and Crumrine

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Flaherty and Crumrine are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable technical and fundamental indicators, Flaherty is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Tekla Life and Flaherty

The main advantage of trading using opposite Tekla Life and Flaherty positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Life position performs unexpectedly, Flaherty can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Flaherty will offset losses from the drop in Flaherty's long position.

The idea behind Tekla Life Sciences and Flaherty and Crumrine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.